US2004219239A1PendingUtilityA1

Nutritional supplement based on blackcurrent seed oil

Priority: Jan 26, 2000Filed: May 27, 2003Published: Nov 4, 2004
Est. expiryJan 26, 2020(expired)· nominal 20-yr term from priority
A61K 8/67A61K 8/23A61K 8/31A23L 33/115A23L 33/16A61Q 19/00A61K 8/922A61Q 19/08A61K 8/676A23L 33/15A23V 2002/00A61P 17/00A61K 8/678A61Q 17/04A61K 8/675A61K 36/185
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the use of a composition comprising an oil with a high content of essential fatty acids of ω3 and ω6 type, preferably black current seed oil, and at least one compound selected from β-carotene, lycopene, tocopherol and its derivatives, tocotrienols and their derivatives, ascorbic acid and nicotinamide, as a nutritional supplement intended for preventing and/or combating the harmful effects of xenobiotics on the skin, in particular, on the skin's immune system.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A composition for reinforcing the immune defenses of the skin and superficial body growths comprising: 
 (a) an oil comprising a high content of essential fatty acids of the type ω3 and ω6; and    (b) at least one compound selected from the group consisting of β-carotene, lycopene, tocopherol, tocopherol derivatives, tocotrienol, tocotrienol derivatives, ascorbic acid, ascorbic acid derivatives, nicotinamide, one or more trace elements and mixtures thereof.    
     
     
         2 . A composition according to  claim 1  wherein said composition further comprises black current seed oil.  
     
     
         3 . A composition according to  claim 2  wherein said composition comprises black current seed oil, β-carotene, lycopene, tocopherol or tocopherol derivatives, ascorbic acid and nicotinamide.  
     
     
         4 . A composition according to  claim 1  wherein one of said trace elements is selenium.  
     
     
         5 . A composition according to  claim 2  wherein said composition comprises at least about 25% by weight of black current seed oil.  
     
     
         6 . A composition according to  claim 5  wherein said composition comprises at least about 50% by weight of black current seed oil.  
     
     
         7 . A composition according to  claim 1  wherein said composition comprises at least about 5% by weight of ascorbic acid.  
     
     
         8 . A composition according to  claim 7  wherein said composition comprises between about 15 and 18% by weight of ascorbic acid.  
     
     
         9 . A composition according to  claim 1  wherein said composition comprises at least about 4% by weight of limonene.  
     
     
         10 . A composition according to  claim 1  wherein said composition comprises at least about 8% by weight of lycopene.  
     
     
         11 . A composition according to  claim 4  wherein said composition comprises at least about 5% by weight of selenium.  
     
     
         12 . A composition according to  claim 11  wherein said composition comprises at least about 10% by weight of selenium.  
     
     
         13 . A composition according to  claim 1  wherein said composition comprises at least about 2% by weight of β-crotene.  
     
     
         14 . A composition according to  claim 13  wherein said composition comprises at least about 4% by weight of β-carotene.  
     
     
         15 . A composition according to  claim 13  herein said composition comprises at least about 1% by weight of nicotinamide.  
     
     
         16 . A composition according to  claim 15  wherein said composition comprises at least about 3% by weight of nicotinamide.  
     
     
         17 . A composition according to  claim 1  wherein said composition comprises at least about 1% by weight of tocopherol or tocopherol derivatives.  
     
     
         18 . A composition according to  claim 1  wherein said composition comprises at least about 2% by weight of copherol derivatives.  
     
     
         19 . A composition according to  claim 1  wherein said tocopherol derivative is tocopheryl acetate.  
     
     
         20 . A composition according to  claim 1  wherein said composition comprises about 53% of black current seed oil, about 4% β-corotne, about 8% lycopene, about 2.2% tocopheryl acetate, from about 15 to about 18% sscorbic acid and about 3% nicotinamide.  
     
     
         21 . A composition according to  claim 1  wherein said composition comprises black current seed oil, carotene, lycopene, tocoheryl acetate ascorbic acid and nicotinamide.  
     
     
         22 . A composition according to  claim 20  wherein said composition further comprises about 10% selenium.  
     
     
         23 . A composition according to  claim 1  wherein said composition further comprises an excipient selected from the group consisting of yellow beeswax, soybean lecithin, glycerol, liquid paraffin and gelatin and mixtures thereof.  
     
     
         24 . A composition according to  claim 1  wherein said composition is in the form of gel capsules suitable for oral administration.  
     
     
         25 . A method of reinforcing the immune defenses of the skin and superficial body growths comprising administering orally to a mammal a composition comprising; 
 (a) (a) an oil comprising a high content of essential fatty acids of the type ω3 and ω6; and    (b) at least one compound selected from the group consisting of β-carotne, lycopene, tocoherol, tocopherol derivative, tocotrienol, tocotrienol derivatives, ascorbic acid, ascorbic acid derivatives, nicotinamide, one or more trace elements and mixtures thereof.    
     
     
         26 . a method of reducing the cytotoxic effects of xenobiotics or Langerhans cells comprising administering orally to a mammal comprising: 
 (a) an oil comprising a high content of essential fatty acids of the type ω3 and ω6; and    (b) at least one compound selected from the group consisting of β-carotene, lycopene, tocoherol, tocopherol derivatives, tocotrienol, tocotrienol derivatives, ascorbic acid, asocribc acid derivatives, nicotinamide, one or more trace elements and mixtures thereof.    
     
     
         27 . a method of combating or preventing photdermatoses comprising administering orally to a mammal a composition comprising; 
 (a) (a) an oil comprising a high content of essential fatty acids of the type ω3 and ω6; and    (b) at least one compound selected from the group consisting of β-carotnee, lycopene, tocopherol, tocopherol derivatives, tocotrienol, tocotrienol derivatives, ascorbic acid, ascorbic acid derivatives, nicotinamide, one or more trace elements and mixtures thereof.    
     
     
         28 . A method of improving the skin's tolerance to sunlight comprising administering orally to a mammal a composition comprising; 
 (a) an oil comprising a high content of essential fatty acids of the type ω3 and ω6; and    (b) at least one compound selected from the group consisting of carotene, lycopee, tocopherol, cooherol derivatives, tocotrienol, tocotrienol derivatives, ascorbic acid, ascorbic acid derivatives, nicotinamide, one or more trade elements and mixtures thereof.    
     
     
         29 . a method of preventing or treating aging of the skin comprising administering orally to a mammal an essential fatty acids of the type ω3 and ω6; and (b) at least one compound selected from the group consisting of β-carotne, lycopene, tocoherol, tocopherol derivatives, tocotrienol, tocotrienol derivatives, ascorbic acid, ascorbic acid derivatives, nicotinamide, one or more trace elements and mixtures thereof.  
     
     
         30 . A method of preventing or treating superficial growths of the skin comprising administering orally to a mammal a composition comprising: 
 (a) an oil comprising a high content of essential fatty acids of the type ω3 and ω6; and    (b) at least one compound selected from the group consisting of β-carotene, lycopene, tocopherol, tocopherol derivatives, tocotrienol, tocotrienol derivatives, ascorbic acid, ascorbic acid derivatives, nicotinamide, one or more trace elements and mixtures thereof.

Join the waitlist — get patent alerts

Track US2004219239A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.